CTNND1 and breast cancer: Of note, expression of just one of these basal B-specific splice variants, which are CTNND1, ENAH and PLOD2, is sufficient to lower the disease-specific survival rate of basal B-like breast cancer patients compared to basal A-like (Additional file 1: Fig. S6b-g).